The metabolic hormone adiponectin affects the correlation between nutritional status and pneumococcal vaccine response in vulnerable indigenous children.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Siegers, Kris Evan Herwaarden, Antonius E
de Waard, Jacobus H
Del Nogal, Berenice
Hermans, Peter W M
van Tienoven, Doorlène
Berbers, Guy A M
de Jonge, Marien I
Verhagen, Lilly M
Type
ArticleOther
Language
en
Metadata
Show full item recordTitle
The metabolic hormone adiponectin affects the correlation between nutritional status and pneumococcal vaccine response in vulnerable indigenous children.Published in
Plos One 2022;17(7):e0270736PMID
35862344ae974a485f413a2113503eed53cd6c53
10.1371/journal.pone.0270736
Scopus Count
Collections
Related articles
- Stunting correlates with high salivary and serum antibody levels after 13-valent pneumococcal conjugate vaccination of Venezuelan Amerindian children.
- Authors: Verhagen LM, Hermsen M, Rivera-Olivero I, Sisco MC, Pinelli E, Hermans PW, Berbers GA, de Waard JH, de Jonge MI
- Issue date: 2016 Apr 29
- Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.
- Authors: Quinet B, Laudat F, Gurtman A, Patterson S, Sidhu M, Gruber WC, Scott DA
- Issue date: 2014 Oct
- Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
- Authors: Nuorti JP, Whitney CG, Centers for Disease Control and Prevention (CDC).
- Issue date: 2010 Dec 10
- 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
- Authors: De Montalembert M, Abboud MR, Fiquet A, Inati A, Lebensburger JD, Kaddah N, Mokhtar G, Piga A, Halasa N, Inusa B, Rees DC, Heath PT, Telfer P, Driscoll C, Al Hajjar S, Tozzi A, Jiang Q, Emini EA, Gruber WC, Gurtman A, Scott DA
- Issue date: 2015 Aug
- Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic.
- Authors: Dunn MG, Lessa FC, Sánchez J, Cordero R, Feris-Iglesias J, Cedano D, Carvalho MDG, Fernández J, Feemster KA
- Issue date: 2021 Sep 1